Cancer Generics 2017 Global Market Outlook,Research,Trends and Forecast to 2022

WiseGuyReports.Com Publish a New Market Research Report On - “Cancer Generics 2017 Global Market Outlook,Research,Trends and Forecast to 2022”.

Pune, India - August 10, 2017 /MarketersMedia/ —

Within the pharmaceutical industry, the oncology market is growing at a rapid pace owing to the rising incidences of cancer. In 2015, 15.2 Million new cancer cases were registered across the globe. This number is forecasted to increase to a value of 19.3 Million by 2025. Furthermore, the patent expiry of blockbuster cancer drugs is another major factor which is propelling the growth of the cancer generics industry.

The report “Global Cancer Generics Market Forecast to 2022”, the global cancer generics market is anticipated to witness a double digit growth during 2016-2022. This report provides a detailed analysis of the current and future market scenario of the global cancer generics market. The report provides insight about the major drivers and challenges, along with the latest trends and developments impacting the industry growth. In addition, the report also highlights various opportunities available for growth of the global cancer generics market.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/1706470-global-cancer-generics-market-forecast-to-2022

For more information or any query mail at [email protected]

The global cancer generics market has been segmented on the basis of mode of administration into oral and injectables. Injectables are the most widely used type of cancer generics drugs. The report also highlights the major cancer generic drugs available in the global market.

Furthermore, the global cancer generics market has also been segmented on the basis of the major indications they are used for. According to the report, breast cancer is expected to account for the largest share in 2016 due to presence of large number of generic drugs and rising incidences of this indication.

Based on geography, the report divides market into North America, Europe, and Asia-Pacific. In 2016, North America is estimated to account for the largest share. Moreover, the report also lists down various mergers and acquisitions taking place in the global generics industry.

The last section of the report discusses about the prominent players in global cancer generics market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios. The recent development of every player has also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global cancer generics market.

Complete Report Details @ https://www.wiseguyreports.com/reports/1706470-global-cancer-generics-market-forecast-to-2022

Table Of Contents – Major Key Points

1. Analyst View

2. Research Methodology

3. Global Cancer Drugs Market Outlook 2022
3.1 Cancer Incidences
3.2 Cancer Drug Market

4. Market Drivers & Challenges
4.1 Drivers
4.1.1 Increasing Cancer Incidences
4.1.2 Strategic Collaborations
4.1.3 Growing Geriatric Population
4.1.4 Ability to Curb Healthcare Cost
4.2 Challenges
4.2.1 Growing Backlog of Generic Drug Applications
4.2.2 Counterfeit Generic Drugs
4.3 Opportunities
4.3.1 Patent Expiry of Blockbuster Oncology Drugs
4.3.2 Generic Cancer Drugs Made More Accessible to Developing Countries

5. Global Cancer Generics Market Analysis 2022

6. Global Cancer Generics Market by Mode of Administration
6.1 Oral Generics
6.1.1 Arimidex (Anastrozole)
6.1.2 Femara (Letrozole)
6.1.3 Hycamtin (Topotecan)
6.1.4 Stivarga (Regorafenib)
6.1.5 Tarceva (Erlotinib)
6.1.6 Xalkori (Crizotinib)
6.1.7 Xeloda (Capecitabine)
6.1.8 Gleevec/Glivec (Imatinib Mesylate)
6.1.9 Nolvadex (Tamoxifen Citrate)
6.1.10 Targretin (Bexarotene)
6.2 Injectables Generics
6.2.1 Camptosar (Irinotecan Hydrochloride)
6.2.2 Eloxatin (Oxaliplatin)
6.2.3 Gemzar (Gemcitabine Hydrochloride)
6.2.4 Navelbine (Vinorelbine Tartrate)
6.2.5 Platinol (Cisplatin)
6.2.6 Taxol (Paclitaxel)
6.2.7 Taxotere (Docetaxel)
6.2.8 Fusilev (Levoleucovorin)
6.2.9 Ellence (Epirubicin Hydrochloride)
6.2.10 Adriamycin (Doxorubicin Hydrochloride)

7. Global Cancer Generics Market by Major Indications
7.1 Lung Cancer
7.2 Breast Cancer
7.3 Colorectal Cancer
7.4 Stomach Cancer
7.5 Prostate Cancer

8. Global Cancer Generics Market by Geographic Regions
8.1 US
8.2 Europe
8.3 Asia-Pacific

9. Trends & Developments
9.1 Generic Version of Blockbuster Cancer Drug
9.2 Entry of Indian Generic Cancer Drug in US

10. Mergers & Acquisitions

11. Key Players
11.1 Fresenius Kabi AG
11.2 Pfizer Inc
11.3 Teva Pharmaceutical Industries Ltd
11.4 Mylan N.V
11.5 Sun Pharmaceutical Industries Ltd
11.6 Sandoz International GmbH - A Novartis Company
11.7 Sanofi
11.8 Dr. Reddy's Laboratories Ltd
11.9 Cipla Ltd
11.10 Apotex Inc

Continue…..

For more information or any query mail at [email protected]

Buy 1-User PDF@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1706470

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: [email protected]
Organization: WiseGuy Research Consultants Pvt Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028
Phone: +1-646-845-9349

Source URL: http://marketersmedia.com/cancer-generics-2017-global-market-outlookresearchtrends-and-forecast-to-2022/227780

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 227780